Ophthalmic Research

Papers
(The H4-Index of Ophthalmic Research is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Neuroprotective Factors of the Retina and Their Role in Promoting Survival of Retinal Ganglion Cells: A Review58
Ocular Pathology and Occasionally Detectable Intraocular Severe Acute Respiratory Syndrome Coronavirus-2 RNA in Five Fatal Coronavirus Disease-19 Cases35
Exosomes Derived from Mouse Adipose-Derived Mesenchymal Stem Cells Alleviate Benzalkonium Chloride-Induced Mouse Dry Eye Model via Inhibiting NLRP3 Inflammasome30
Novel Data about Association of the Functionally Significant Polymorphisms of the <b><i>MMP9</i></b> Gene with Exfoliation Glaucoma in the Caucasian Population of Central Russi25
The Role of Gut Microbiome in Autoimmune Uveitis24
Effectiveness of iStent Trabecular Microbypass System Combined with Phacoemulsification versus Phacoemulsification Alone in Patients with Glaucoma and Cataract Depending on the Initial Intraocular Pre21
Combined Orthokeratology with Atropine for Children with Myopia: A Meta-Analysis20
Prevalence and Incidence of Dry Eye Disease in Asia: A Systematic Review and Meta-Analysis20
Standardization of Optical Coherence Tomography Angiography Imaging Biomarkers in Diabetic Retinal Disease19
Pathophysiology of Age-Related Macular Degeneration: Implications for Treatment19
IOL Formula Constants: Strategies for Optimization and Defining Standards for Presenting Data18
Anti-VEGF Therapy Reduces Inflammation in Diabetic Macular Edema16
Role of Oxidative Stress and Severity of Diabetic Retinopathy in Type 1 and Type 2 Diabetes15
Higher TGF-β1, TGF-β2, MMP-2, and TIMP-1 Levels in the Aqueous Humor of Patients with Acute Primary Angle Closure15
Growth Rate of Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Meta-Analysis of Natural History Studies and Implications for Designing Future Trials14
0.023560047149658